H.C. Wainwrigh on United Therapeutics Corp. (UTHR): 'We believe ralinepag is a win mechanistically and clinically'
Tweet Send to a Friend
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating and $600.00 price target on United Therapeutics Corp. (NASDAQ: UTHR).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
